Tag: #Global Trends

The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Immedica Pharma's Loargys (pegzilarginase) for the treatment... Read more

Seeking to bolster its presence in the Chinese market, Pfizer has entered into a strategic agreement worth up to $495... Read more

AstraZeneca's board has disclosed that CEO Pascal Soriot's realized compensation for 2025 reached 17.7 million pounds ($23.9 million). This represents... Read more

BioMarin Pharmaceutical has announced the withdrawal of Roctavian, the first one-time gene therapy for hemophilia A, after failing to secure... Read more

Pharmaceutical giant Novo Nordisk has announced plans to significantly slash the wholesale acquisition cost (WAC) in the United States for... Read more

A recent study published in the journal Frontiers in Microbiology has identified a bacterial strain named Psychrobacter SC65A.3 within the... Read more

Merck and the Mayo Clinic have announced a strategic R&D agreement to integrate artificial intelligence, advanced analytics, and multimodal clinical... Read more

Novartis has entered a multi-billion dollar research collaboration and licensing agreement with Unnatural Products Inc. (UNP) to target historically "undruggable"... Read more

Zifo and Maze Therapeutics have launched a collaboration to develop scalable solutions for managing vast and fragmented biobank datasets. By... Read more